Evidence map›Paper›PMID 32973645›Full record

ArticleFrontiers in neurology2020

Usefulness of PET With [

Maria-Joao Ribeiro, Johnny Vercouillie, Nicolas Arlicot, Clovis Tauber, Valérie Gissot, Karl Mondon, Laurent Barantin, Jean-Philippe Cottier, Serge Maia, Jean-Bernard Deloye and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Let's celebrate 25 years of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Synthesis and Biological Evaluation of [Molecular imaging and biology · 2021
    Article
  8. Fully automated radiosynthesis of [EJNMMI radiopharmacy and chemistry · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Maria-Joao RibeiroUMR 1253, iBrain, Université de Tours, Tours, France.
Johnny VercouillieUMR 1253, iBrain, Université de Tours, Tours, France.
Nicolas ArlicotUMR 1253, iBrain, Université de Tours, Tours, France.
Clovis TauberUMR 1253, iBrain, Université de Tours, Tours, France.
Valérie GissotCHRU, Tours, France.
Karl MondonCHRU, Tours, France.
Laurent BarantinUMR 1253, iBrain, Université de Tours, Tours, France.
Jean-Philippe CottierUMR 1253, iBrain, Université de Tours, Tours, France.
Serge MaiaCHRU, Tours, France.
Jean-Bernard DeloyeZionexa, Saint-Beauzire, France.
Patrick EmondUMR 1253, iBrain, Université de Tours, Tours, France.
Denis GuilloteauUMR 1253, iBrain, Université de Tours, Tours, France.
Centre Hospitalier Universitaire de Tours · FRUniversité de Tours · FRClinical Investigation Center Plurithematic Tours · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DATdopamineParkinson's diseasePETradiopharmaceutical

Identifiers

PMID32973645
PMCPMC7472558
OpenAlexW3080216490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.